C17orf37, whose expression correlates with grade and stage of nIBC [83], promotes invasion and migration of prostate cancer cells by enhancing secretion of uPA, MMP9 and VEGF through NF-kB pathway [84]. Here, MMP9 is linked to prostate carcinoma.